Related Experiment Video
Updated: Dec 2, 2025

07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
983
Gleason grade 5 prostate cancer: sub-patterns and prognosis
Chantal Atallah1, Ants Toi2, Theodorus H van der Kwast3
1Département de médecine de laboratoire, Service clinique d'anatomopathologie, Université Laval, Québec, Canada.
Pathology
|November 4, 2020
Summary
Gleason pattern 5 (GP5) in prostate cancer grading has evolving definitions. While GP5 indicates poor prognosis, the impact of its specific sub-patterns requires further investigation.
Area of Science:
- Uropathology
- Prostate Cancer Grading
- Oncologic Pathology
Background:
- The Gleason grading system for prostate cancer has undergone modifications, particularly regarding Gleason pattern 5 (GP5) and its sub-patterns.
- Comedonecrosis's classification as a GP5 pattern has been debated and revised by the International Society of Urological Pathology (ISUP).
- Gleason pattern 5 is associated with an unfavorable prognosis, including increased risk of metastasis and disease-specific death.
Purpose of the Study:
- To review the evolving definitions and reporting of Gleason pattern 5 (GP5) and its sub-patterns in prostate cancer.
- To investigate the potential reasons for an observed increase in GP5 diagnoses over time.
- To highlight the need for further research into the prognostic impact of individual GP5 sub-patterns.
Main Methods:
- Review of historical definitions and ISUP guidelines for Gleason pattern 5 (GP5).
- Analysis of biopsy and prostatectomy specimen reporting trends.
- Institutional biopsy review study to assess changes in GP5 diagnosis over time.
Main Results:
- Gleason pattern 5 (GP5) definitions and sub-patterns, including comedonecrosis, have evolved.
- An institutional review showed an increase in GP5 diagnosis, not linked to new sub-patterns or overdiagnosis.
- The most common GP5 sub-patterns in biopsies are single files and single cells; frequency is 1-5% in most series.
Conclusions:
- The reporting and definition of Gleason pattern 5 (GP5) in prostate cancer have changed over time.
- An increase in GP5 diagnosis may be related to evolving biopsy indications rather than diagnostic changes.
- Further research is crucial to understand the prognostic significance of individual GP5 sub-patterns and their molecular basis.

